$KVA, KVB Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in K-V Pharmaceutical Co.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in K-V Pharmaceutical Co. Get notifications about new insider transactions in K-V Pharmaceutical Co for free.

Page: 1 2 3 4 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Nov 20 2013	KVA, KVB	K-V Pharmaceutical ...	Silver Point Capital L.P.	10% Owner	Buy	P	46.50	25,000	1,162,500	2,023,883	2 M to 2 M (+1.25 %)
Nov 15 2013	KVA, KVB	K-V Pharmaceutical ...	Silver Point Capital L.P.	10% Owner	Buy	P	44.50	50,000	2,225,000	1,998,883	1.9 M to 2 M (+2.57 %)
Nov 15 2013	KVA, KVB	K-V Pharmaceutical ...	Silver Point Capital L.P.	10% Owner	Buy	P	42.75	57,162	2,443,676	1,948,883	1.9 M to 1.9 M (+3.02 %)
Nov 01 2013	KVA, KVB	K-V Pharmaceutical ...	Vergis Janet S.	Director	Option Exercise	A	0.00	3,751	0	3,751
Nov 01 2013	KVA, KVB	K-V Pharmaceutical ...	Vergis Janet S.	Director	Option Exercise	A	32.00	5,000	160,000	5,000
Nov 01 2013	KVA, KVB	K-V Pharmaceutical ...	Vergis Janet S.	Director	Option Exercise	A	28.80	15,000	432,000	15,000
Oct 25 2013	KVA, KVB	K-V Pharmaceutical ...	MAHADY JOSEPH M	Director	Option Exercise	A	0.00	7,142	0	7,142
Oct 25 2013	KVA, KVB	K-V Pharmaceutical ...	MAHADY JOSEPH M	Director	Option Exercise	A	32.00	10,000	320,000	10,000
Oct 25 2013	KVA, KVB	K-V Pharmaceutical ...	MAHADY JOSEPH M	Director	Option Exercise	A	28.80	30,000	864,000	30,000
Oct 23 2013	KVA, KVB	K-V Pharmaceutical ...	Goldfarb James M.	Director	Option Exercise	A	0.00	3,751	0	3,751
Oct 23 2013	KVA, KVB	K-V Pharmaceutical ...	Goldfarb James M.	Director	Option Exercise	A	32.00	5,000	160,000	5,000
Oct 23 2013	KVA, KVB	K-V Pharmaceutical ...	Goldfarb James M.	Director	Option Exercise	A	28.80	15,000	432,000	15,000
Oct 23 2013	KVA, KVB	K-V Pharmaceutical ...	Norden Gregory	Director	Option Exercise	A	0.00	3,751	0	3,751
Oct 23 2013	KVA, KVB	K-V Pharmaceutical ...	Norden Gregory	Director	Option Exercise	A	32.00	5,000	160,000	5,000
Oct 23 2013	KVA, KVB	K-V Pharmaceutical ...	Norden Gregory	Director	Option Exercise	A	28.80	15,000	432,000	15,000
Oct 04 2013	KVA, KVB	K-V Pharmaceutical ...	Christmas Patrick J.	General Counsel	Option Exercise	A	20.00	40,327	806,540	40,327
Oct 04 2013	KVA, KVB	K-V Pharmaceutical ...	Christmas Patrick J.	General Counsel	Option Exercise	A	0.00	86,806	0	86,806
Oct 04 2013	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	A	20.00	80,653	1,613,060	80,653
Oct 04 2013	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	A	0.00	173,611	0	173,611
Oct 04 2013	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	A	20.00	40,327	806,540	40,327
Oct 04 2013	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	A	0.00	86,806	0	86,806
Sep 24 2013	KVA, KVB	K-V Pharmaceutical ...	Christmas Patrick J.	General Counsel	Option Exercise	J	1.32	40,000	52,800	0
Sep 24 2013	KVA, KVB	K-V Pharmaceutical ...	Christmas Patrick J.	General Counsel	Option Exercise	J	3.32	40,000	132,800	0
Sep 20 2013	KVA, KVB	K-V Pharmaceutical ...	SIDRANSKY DAVID	Director	Option Exercise	J	0.94	20,000	18,800	0
Sep 20 2013	KVA, KVB	K-V Pharmaceutical ...	SIDRANSKY DAVID	Director	Option Exercise	J	1.49	20,000	29,800	0
Sep 20 2013	KVA, KVB	K-V Pharmaceutical ...	SIDRANSKY DAVID	Director	Option Exercise	J	1.02	7,500	7,650	0
Sep 20 2013	KVA, KVB	K-V Pharmaceutical ...	SIDRANSKY DAVID	Director	Option Exercise	J	1.62	10,000	16,200	0
Sep 20 2013	KVA, KVB	K-V Pharmaceutical ...	SIDRANSKY DAVID	Director	Sell	J	0.00	1,000	0	0	1,000 to 0 (-100.00 %)
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	J	1.32	100,000	132,000	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	J	1.49	70,000	104,300	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	J	1.62	50,000	81,000	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	J	1.52	10,000	15,200	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	J	2.95	70,000	206,500	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	J	28.60	28,775	822,965	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Sell	J	0.00	1,225	0	0	1.2 K to 0 (-100.00 %)
Sep 19 2013	KVA, KVB	K-V Pharmaceutical ...	LEHRER JOSEPH D	Director	Option Exercise	J	0.94	30,000	28,200	0
Sep 19 2013	KVA, KVB	K-V Pharmaceutical ...	LEHRER JOSEPH D	Director	Option Exercise	J	1.49	30,000	44,700	0
Sep 19 2013	KVA, KVB	K-V Pharmaceutical ...	LEHRER JOSEPH D	Director	Option Exercise	J	1.11	7,500	8,325	0
Sep 19 2013	KVA, KVB	K-V Pharmaceutical ...	LEHRER JOSEPH D	Director	Option Exercise	J	1.62	10,000	16,200	0
Sep 19 2013	KVA, KVB	K-V Pharmaceutical ...	LEHRER JOSEPH D	Director	Sell	J	0.00	100	0	0	100 to 0 (-100.00 %)
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	J	1.32	35,000	46,200	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	J	1.49	35,000	52,150	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	J	1.14	25,000	28,500	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	J	1.62	20,000	32,400	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	J	1.52	5,000	7,600	0
Sep 18 2013	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	J	1.40	20,000	28,000	0
Aug 07 2013	KVA, KVB	K-V Pharmaceutical ...	GLENVIEW CAPITAL MANAGEMENT, L ...	10% Owner	Sell	P	0.46	1,764,709	820,413	4,897,274	6.7 M to 4.9 M (-26.49 %)
Aug 05 2013	KVA, KVB	K-V Pharmaceutical ...	GLENVIEW CAPITAL MANAGEMENT, L ...	10% Owner	Buy	P	0.55	703,000	386,650	6,661,983	6 M to 6.7 M (+11.80 %)
Aug 05 2013	KVA, KVB	K-V Pharmaceutical ...	GLENVIEW CAPITAL MANAGEMENT, L ...	10% Owner	Buy	P	0.58	800,000	464,000	5,958,983	5.2 M to 6 M (+15.51 %)
Sep 27 2013	KVA, KVB	K-V Pharmaceutical ...	Stancic Ana	Director	Option Exercise	J	0.94	20,000	18,800	0
Sep 27 2013	KVA, KVB	K-V Pharmaceutical ...	Stancic Ana	Director	Option Exercise	J	1.49	20,000	29,800	0
Sep 27 2013	KVA, KVB	K-V Pharmaceutical ...	Stancic Ana	Director	Option Exercise	J	1.14	7,500	8,550	0
Sep 27 2013	KVA, KVB	K-V Pharmaceutical ...	Stancic Ana	Director	Option Exercise	J	1.62	10,000	16,200	0
Sep 27 2013	KVA, KVB	K-V Pharmaceutical ...	BALDINI ROBERT E	Director	Option Exercise	J	0.94	20,000	18,800	0
Sep 27 2013	KVA, KVB	K-V Pharmaceutical ...	BALDINI ROBERT E	Director	Option Exercise	J	1.49	20,000	29,800	0
Sep 27 2013	KVA, KVB	K-V Pharmaceutical ...	BALDINI ROBERT E	Director	Option Exercise	J	1.23	7,500	9,225	0
Sep 27 2013	KVA, KVB	K-V Pharmaceutical ...	BALDINI ROBERT E	Director	Option Exercise	J	1.62	10,000	16,200	0
Sep 27 2013	KVA, KVB	K-V Pharmaceutical ...	Silver Point Capital L.P.	10% Owner	Sell	S	40.00	199,000	7,960,000	1,516,721	1.7 M to 1.5 M (-11.60 %)
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Dow Mark A.	Director	Option Exercise	J	0.94	20,000	18,800	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Dow Mark A.	Director	Option Exercise	J	1.49	20,000	29,800	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Dow Mark A.	Director	Option Exercise	J	1.11	7,500	8,325	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Dow Mark A.	Director	Option Exercise	J	1.62	10,000	16,200	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Director	Option Exercise	J	0.94	20,000	18,800	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Director	Option Exercise	J	1.49	20,000	29,800	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Director	Option Exercise	J	1.62	10,000	16,200	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Director	Option Exercise	J	2.95	15,000	44,250	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Director	Sell	J	0.00	2,136,555	0	0	2.1 M to 0 (-100.00 %)
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Director	Sell	J	0.00	1,343,187	0	0	1.3 M to 0 (-100.00 %)
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Director	Sell	J	0.00	52,875	0	0	52.9 K to 0 (-100.00 %)
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Director	Sell	J	0.00	15,375	0	0	15.4 K to 0 (-100.00 %)
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	BENTLEY GREGORY SMITH	Director	Option Exercise	J	0.94	20,000	18,800	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	BENTLEY GREGORY SMITH	Director	Option Exercise	J	1.49	20,000	29,800	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	BENTLEY GREGORY SMITH	Director	Option Exercise	J	1.11	7,500	8,325	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	BENTLEY GREGORY SMITH	Director	Option Exercise	J	1.62	35,000	56,700	0
Sep 26 2013	KVA, KVB	K-V Pharmaceutical ...	BENTLEY GREGORY SMITH	Director	Sell	J	0.00	10	0	0	10 to 0 (-100.00 %)
Sep 25 2013	KVA, KVB	K-V Pharmaceutical ...	Silver Point Capital L.P.	10% Owner	Buy	P	40.00	150,000	6,000,000	1,715,721	1.6 M to 1.7 M (+9.58 %)
Feb 07 2013	KVA, KVB	K-V Pharmaceutical ...	Parkside Financial Bank & Trus ...	10% Owner	Buy	C	0.00	1,402,145	0	1,402,145	0 to 1.4 M
Feb 07 2013	KVA, KVB	K-V Pharmaceutical ...	Parkside Financial Bank & Trus ...	10% Owner	Sell	C	0.00	1,402,145	0	0	1.4 M to 0 (-100.00 %)
May 16 2012	KVA, KVB	K-V Pharmaceutical ...	BALDINI ROBERT E	Director	Option Exercise	A	0.94	20,000	18,800	20,000
May 16 2012	KVA, KVB	K-V Pharmaceutical ...	Dow Mark A.	Director	Option Exercise	A	0.94	20,000	18,800	20,000
May 16 2012	KVA, KVB	K-V Pharmaceutical ...	BENTLEY GREGORY SMITH	Director	Option Exercise	A	0.94	20,000	18,800	20,000
May 16 2012	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Director	Option Exercise	A	0.94	20,000	18,800	20,000
May 16 2012	KVA, KVB	K-V Pharmaceutical ...	SIDRANSKY DAVID	Director	Option Exercise	A	0.94	20,000	18,800	20,000
May 16 2012	KVA, KVB	K-V Pharmaceutical ...	Stancic Ana	Director	Option Exercise	A	0.94	20,000	18,800	20,000
May 16 2012	KVA, KVB	K-V Pharmaceutical ...	LEHRER JOSEPH D	Director	Option Exercise	A	0.94	30,000	28,200	30,000
Mar 30 2012	KVA, KVB	K-V Pharmaceutical ...	Christmas Patrick J.	General Counsel	Option Exercise	A	1.32	40,000	52,800	40,000
Mar 30 2012	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	A	1.32	100,000	132,000	100,000
Mar 30 2012	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	A	1.32	35,000	46,200	35,000
Sep 12 2011	KVA, KVB	K-V Pharmaceutical ...	BALDINI ROBERT E	Director	Option Exercise	A	1.49	20,000	29,800	20,000
Sep 12 2011	KVA, KVB	K-V Pharmaceutical ...	BENTLEY GREGORY SMITH	Director	Option Exercise	A	1.49	20,000	29,800	20,000
Sep 12 2011	KVA, KVB	K-V Pharmaceutical ...	Dow Mark A.	Director	Option Exercise	A	1.49	20,000	29,800	20,000
Sep 12 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Director	Option Exercise	A	1.49	20,000	29,800	20,000
Sep 12 2011	KVA, KVB	K-V Pharmaceutical ...	LEHRER JOSEPH D	Director	Option Exercise	A	1.49	30,000	44,700	30,000
Sep 12 2011	KVA, KVB	K-V Pharmaceutical ...	SIDRANSKY DAVID	Director	Option Exercise	A	1.49	20,000	29,800	20,000
Sep 12 2011	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	A	1.49	35,000	52,150	35,000
Sep 12 2011	KVA, KVB	K-V Pharmaceutical ...	Stancic Ana	Director	Option Exercise	A	1.49	20,000	29,800	20,000
Sep 12 2011	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	A	1.49	70,000	104,300	70,000
May 18 2011	KVA, KVB	K-V Pharmaceutical ...	Christmas Patrick J.	General Counsel	Option Exercise	A	2.89	40,000	115,600	40,000
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.37	5,000	51,850	289,179	294.2 K to 289.2 K (-1.70 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.35	5,000	51,750	294,179	299.2 K to 294.2 K (-1.67 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.33	3,800	39,254	299,179	303 K to 299.2 K (-1.25 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.32	10,000	103,200	302,979	313 K to 303 K (-3.20 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.30	16,200	166,860	312,979	329.2 K to 313 K (-4.92 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.25	5,000	51,250	329,179	334.2 K to 329.2 K (-1.50 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.23	6,600	67,518	334,179	340.8 K to 334.2 K (-1.94 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.22	3,900	39,858	340,779	344.7 K to 340.8 K (-1.13 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.21	400	4,084	344,679	345.1 K to 344.7 K (-0.12 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.20	14,100	143,820	345,079	359.2 K to 345.1 K (-3.93 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.19	5,000	50,950	359,179	364.2 K to 359.2 K (-1.37 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.18	320	3,258	364,179	364.5 K to 364.2 K (-0.09 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.16	4,680	47,549	364,499	369.2 K to 364.5 K (-1.27 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.15	5,000	50,750	369,179	374.2 K to 369.2 K (-1.34 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.12	6,700	67,804	374,179	380.9 K to 374.2 K (-1.76 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.11	1,000	10,110	380,879	381.9 K to 380.9 K (-0.26 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.10	5,400	54,540	381,879	387.3 K to 381.9 K (-1.39 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.09	300	3,027	387,279	387.6 K to 387.3 K (-0.08 %)
Mar 08 2011	KVA, KVB	K-V Pharmaceutical ...	Hermelin Arnold L	10% Owner	Sell	S	10.08	1,600	16,128	387,579	389.2 K to 387.6 K (-0.41 %)
Feb 17 2011	KVA, KVB	K-V Pharmaceutical ...	Parkside Financial Bank & Trus ...	10% Owner	Sell	J	0.00	120,000	0	761,526	881.5 K to 761.5 K (-13.61 %)
Feb 08 2011	KVA, KVB	K-V Pharmaceutical ...	Parkside Financial Bank & Trus ...	10% Owner	Sell	J	0.00	192,900	0	881,526	1.1 M to 881.5 K (-17.95 %)
Feb 08 2011	KVA, KVB	K-V Pharmaceutical ...	Parkside Financial Bank & Trus ...	10% Owner	Sell	S	3.81	125,000	476,838	1,074,426	1.2 M to 1.1 M (-10.42 %)
Feb 08 2011	KVA, KVB	K-V Pharmaceutical ...	Parkside Financial Bank & Trus ...	10% Owner	Buy	C	0.00	832,000	0	1,199,426	367.4 K to 1.2 M (+226.44 %)
Feb 08 2011	KVA, KVB	K-V Pharmaceutical ...	Parkside Financial Bank & Trus ...	10% Owner	Sell	C	0.00	832,000	0	1,402,145	2.2 M to 1.4 M (-37.24 %)
Nov 17 2010	KVA, KVB	K-V Pharmaceutical ...	HERMELIN MARC S	10% Owner	Sell	J	0.00	2,098	0	0	2.1 K to 0 (-100.00 %)
Nov 17 2010	KVA, KVB	K-V Pharmaceutical ...	HERMELIN MARC S	10% Owner	Sell	J	0.00	2,246,209	0	0	2.2 M to 0 (-100.00 %)
Nov 17 2010	KVA, KVB	K-V Pharmaceutical ...	HERMELIN MARC S	10% Owner	Sell	J	0.00	200	0	0	200 to 0 (-100.00 %)
Nov 17 2010	KVA, KVB	K-V Pharmaceutical ...	HERMELIN MARC S	10% Owner	Sell	J	0.00	917,672	0	0	917.7 K to 0 (-100.00 %)
Oct 13 2010	KVA, KVB	K-V Pharmaceutical ...	HERMELIN MARC S	Director	Sell	J	0.00	82,640	0	917,672	1 M to 917.7 K (-8.26 %)
Sep 30 2010	KVA, KVB	K-V Pharmaceutical ...	HERMELIN MARC S	Director	Gift	G	0.00	104,348	0	851,688	956 K to 851.7 K (-10.91 %)
Sep 15 2010	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	A	1.14	25,000	28,500	25,000
Sep 14 2010	KVA, KVB	K-V Pharmaceutical ...	HERMELIN MARC S	Director	Option Exercise	A	1.62	10,000	16,200	10,000
Sep 14 2010	KVA, KVB	K-V Pharmaceutical ...	HERMELIN MARC S	Director	Option Exercise	A	2.95	15,000	44,250	15,000
Sep 13 2010	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Vice President	Option Exercise	A	1.62	10,000	16,200	10,000
Sep 13 2010	KVA, KVB	K-V Pharmaceutical ...	Hermelin David S	Vice President	Option Exercise	A	2.95	15,000	44,250	15,000
Sep 13 2010	KVA, KVB	K-V Pharmaceutical ...	SIDRANSKY DAVID	Director	Option Exercise	A	1.62	10,000	16,200	10,000
Sep 10 2010	KVA, KVB	K-V Pharmaceutical ...	LEHRER JOSEPH D	Director	Option Exercise	A	1.62	10,000	16,200	10,000
Sep 09 2010	KVA, KVB	K-V Pharmaceutical ...	Stancic Ana	Director	Option Exercise	A	1.62	10,000	16,200	10,000
Sep 09 2010	KVA, KVB	K-V Pharmaceutical ...	BALDINI ROBERT E	Director	Option Exercise	A	1.62	10,000	16,200	10,000
Sep 09 2010	KVA, KVB	K-V Pharmaceutical ...	Dow Mark A.	Director	Option Exercise	A	1.62	10,000	16,200	10,000
Sep 09 2010	KVA, KVB	K-V Pharmaceutical ...	BENTLEY GREGORY SMITH	Senior VP - Law Sec ...	Option Exercise	A	1.62	35,000	56,700	35,000
Sep 09 2010	KVA, KVB	K-V Pharmaceutical ...	MCHUGH THOMAS S	Chief Financial Off ...	Option Exercise	A	1.62	20,000	32,400	20,000
Sep 09 2010	KVA, KVB	K-V Pharmaceutical ...	DIVIS GREG J	CEO and President	Option Exercise	A	1.62	50,000	81,000	50,000
Aug 12 2010	KVA, KVB	K-V Pharmaceutical ...	BALDINI ROBERT E	Director	Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jul 08 2010	KVA, KVB	K-V Pharmaceutical ...	SIDRANSKY DAVID	Director	Grant	A	0.00	7,500	0	8,500	1,000 to 8.5 K (+750.00 %)
Jul 12 2010	KVA, KVB	K-V Pharmaceutical ...	Stancic Ana	Director	Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jun 16 2010	KVA, KVB	K-V Pharmaceutical ...	Dow Mark A.	Director	Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jun 14 2010	KVA, KVB	K-V Pharmaceutical ...	Sampson John R.	Director	Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jun 14 2010	KVA, KVB	K-V Pharmaceutical ...	BENTLEY GREGORY SMITH	Executive Officer	Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Jun 14 2010	KVA, KVB	K-V Pharmaceutical ...	LEHRER JOSEPH D	Director	Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Apr 12 2010	KVA, KVB	K-V Pharmaceutical ...	Stamp Stephen	CFO	Option Exercise	A	0.00	50,000	0	50,000
Jan 20 2010	KVA, KVB	K-V Pharmaceutical ...	Forsyth Janice C.	VP, Gen. Counsel & ...	Grant	A	0.00	40,000	0	40,000	0 to 40 K

Page: 1 2 3 4 4 next >